Protein kinase C activity and protein levels in Alzheimer's disease

Patients with Alzheimer's disease (AD) have been reported to have abnormalities in the levels and activities of protein kinase C (PKC) in brain and other tissues. We have measured Ca 2+-activated, phospholipid-dependent PKC activities and levels in cerebral cortex from frontal, motor, temporal...

Full description

Saved in:
Bibliographic Details
Published inBrain research Vol. 764; no. 1; pp. 75 - 80
Main Authors Lanius, R.A, Wagey, R, Sahl, B, Beattie, B.L, Feldman, H, Pelech, S.L, Krieger, C
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Patients with Alzheimer's disease (AD) have been reported to have abnormalities in the levels and activities of protein kinase C (PKC) in brain and other tissues. We have measured Ca 2+-activated, phospholipid-dependent PKC activities and levels in cerebral cortex from frontal, motor, temporal and parietal regions, as well as in leukocytes and platelets from AD patients and controls. No significant differences in PKC histone H1 phosphotransferase activity were seen in frontal, motor, temporal or parietal cortex, or in leukocytes and platelets from AD patients and controls. Elevated PKC protein was present in cytosolic fractions from frontal cortex, but not in other brain regions, or in leukocytes and platelets. These data suggest that abnormalities of PKC phosphorylating activity are absent in AD.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0006-8993
1872-6240
DOI:10.1016/S0006-8993(97)00422-8